A few weeks ago at the 65th Annual Meeting of the American Academy of Neurology held in San Diego, California, the ALS Association and the American Academy of Neurology announced the recipients of two ALS research awards. James Berry, M.D., M.P.H., in the Department of Neurology at Massachusetts General Hospital in Boston, Massachusetts was presented with the Richard Olney AAN/ALS Association Clinician Scientist Development Award. Dr. Berry will use this award to study ALS-associated changes in the immune system, which could one day be used as an ALS biomarker. The award is named in honor of ALS researcher and neurologist, Richard K. Olney, M.D., who passed away after a battle with ALS in 2012. Additionally, the Sheila Essey Award for ALS Research was presented to Rosa Rademakers, Ph.D., Associate Professor of Neuroscience at the Mayo Clinic College of Medicine in Jacksonville, Florida, and Bryan Traynor, M.D., Ph.D., Chief of the Neuromuscular Diseases Research Unit at the National Institute on Aging Laboratory of Neurogenetics, for their independent work that led to the identification of C9ORF72. The Sheila Essey Award, provided by the Essey Family Fund, is in memory of Sheila Essey who passed away after a battle with ALS in 2004.
conf-american-academy-of-neurology-annual-meeting disease-als topic-clinicalShare this: